Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lung Neoplasms 1 Carcinoma, Basal Cell 1

Interventions

HhAntag691 21 Biopsy 11 Imiquimod 10 Aminolevulinic Acid 9 sonidegib 8 Photochemotherapy 8 Nivolumab 8 1-phenyl-3,3-dimethyltriazene 7 methyl 5-aminolevulinate 6 cemiplimab 6 Surgical Procedures, Operative 5 Specimen Handling 5 Radiotherapy 5 Itraconazole 5 pembrolizumab 4 daromun 4 Mohs Surgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Curettage 4 Tomography, Optical Coherence 3 Standard of Care 3 Niacinamide 3 Microscopy, Confocal 3 IPI-926 3 CTLA-4 Antigen 3 3-ingenyl angelate 3 tazarotene 2 talimogene laherparepvec 2 relatlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Basal Cell × Immunologic Factors × Clear all

NCT00803907 2012-06-13

Imiquimod

University of Sao Paulo

Phase 4 Unknown

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡